Home65G • FRA
add
NextCell Pharma AB
Previous close
€0.092
Day range
€0.088 - €0.088
Year range
€0.057 - €0.29
Market cap
83.03M SEK
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | 3.42M | 42.07% |
Operating expense | 9.30M | -7.42% |
Net income | -8.20M | 18.77% |
Net profit margin | -239.96 | 42.83% |
Earnings per share | — | — |
EBITDA | -7.82M | 23.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.34M | -13.34% |
Total assets | 61.47M | -12.86% |
Total liabilities | 10.11M | -31.22% |
Total equity | 51.36M | — |
Shares outstanding | 73.09M | — |
Price to book | 0.13 | — |
Return on assets | -32.34% | — |
Return on capital | -38.13% | — |
Cash Flow
Net change in cash
| (SEK) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -8.20M | 18.77% |
Cash from operations | -6.45M | 36.66% |
Cash from investing | -1.57M | -3,879.35% |
Cash from financing | 234.11K | 28.26% |
Net change in cash | -7.78M | 22.43% |
Free cash flow | -5.11M | 22.90% |
About
Founded
2014
Website
Employees
24
